l General Information |
Product Name | Trospium chloride |
General description | Trospium chloride is a muscarinic antagonist urinary antispasmodic. |
Synonym | [(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2 diphenylacetate;chloride; Sanctura; Keptan; Relaspium |
Purity | ≥98%(HPLC) | CAS Number | 10405-02-4 |
Formula | C25H30ClNO3 | Molecular Weight | 427.969 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥35mg/mL |
Ethanol | ≥35mg/mL |
Water | ≥50mg/mL |
l Biological Information |
Biochem/Physiol Actions | Trospium is an antispasmotic and anticholinergic agent used to treat urinary incontinence and overactive bladder syndrome. Trospium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. |
Application | 1. Muscarinic Antagonists 2. Parasympatholytics 3. Urological Agents |
l Packaging & Storage |
Packaging | 50mg; 250mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
